Eli Lilly's stock price is comfortably above $1,000, and management could easily justify doing a stock split.

Eli Lilly has split four times since 1986, with the latest split implemented in October 1997. Today, the company, surging in recent years thanks to the success of its GLP-1 weight loss drug Zepbound, ...

Lilly, the seller of blockbuster GLP-1 drugs, has seen revenue take off, and that has prompted both cautious and more ...

The current "stock split watch" surrounding Eli Lilly is a direct consequence of its phenomenal performance over the past year. As of November 18, 2025, the company's stock closed at an impressive ...

AutoZone, Eli Lilly, Meta Platforms, and Costco all trade at high share prices, making them candidates for stock splits as analysts raise price targets and cite strong fundamentals.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly hasn't split its stock in nearly 30 years, but as shares trade above $1,000, the pharmaceutical company could be considering one. Considering other high-profile stock splits in recent years, ...

Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for their promise of steady gains over the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...